Metal-phenolic capsules with ROS scavenging reshape the oxidative microenvironment of atherosclerosis
Copyright © 2023 Elsevier Inc. All rights reserved..
Arterial injury makes the tissue in a state of high oxidative stress. At the same time, abnormal lipid metabolism can further lead to bleeding and thrombosis. Therefore, the anti-inflammatory and anti-oxidant polyphenol, EGCG was organically complexed with Fe3+ to form a metal-phenolic framework carrier. And the antihyperlipidemic drug, atorvastatin (ATV) was loaded into the carrier to enhance the bioavailability, and simultaneously alleviate the oxidative stress of the inflammatory site and abnormal lipid metabolism. The results confirmed that the obtained material EGCG-Fe-ATV had good biocompatibility and biosafety effect. In addition, EGCG-Fe-ATV showed outstanding anti-inflammatory, anti-oxidant and lipid-lowering properties. These therapeutic outcomes of EGCG-Fe-ATV were achieved by reducing systemic and local oxidative stress and inflammation, alleviating inflammatory cell infiltration in plaques, and modulating lipid synthesis and transferase to alter cholesterol transport. In conclusion, the combination of metal-phenolic capsules with ATV provides a new strategy for reshaping the oxidative microenvironment of atherosclerosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
---|---|
Enthalten in: |
Nanomedicine : nanotechnology, biology, and medicine - 53(2023) vom: 10. Sept., Seite 102700 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Aiai [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.09.2023 Date Revised 27.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.nano.2023.102700 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360440223 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360440223 | ||
003 | DE-627 | ||
005 | 20231226083022.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.nano.2023.102700 |2 doi | |
028 | 5 | 2 | |a pubmed24n1201.xml |
035 | |a (DE-627)NLM360440223 | ||
035 | |a (NLM)37544347 | ||
035 | |a (PII)S1549-9634(23)00051-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Aiai |e verfasserin |4 aut | |
245 | 1 | 0 | |a Metal-phenolic capsules with ROS scavenging reshape the oxidative microenvironment of atherosclerosis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.09.2023 | ||
500 | |a Date Revised 27.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a Arterial injury makes the tissue in a state of high oxidative stress. At the same time, abnormal lipid metabolism can further lead to bleeding and thrombosis. Therefore, the anti-inflammatory and anti-oxidant polyphenol, EGCG was organically complexed with Fe3+ to form a metal-phenolic framework carrier. And the antihyperlipidemic drug, atorvastatin (ATV) was loaded into the carrier to enhance the bioavailability, and simultaneously alleviate the oxidative stress of the inflammatory site and abnormal lipid metabolism. The results confirmed that the obtained material EGCG-Fe-ATV had good biocompatibility and biosafety effect. In addition, EGCG-Fe-ATV showed outstanding anti-inflammatory, anti-oxidant and lipid-lowering properties. These therapeutic outcomes of EGCG-Fe-ATV were achieved by reducing systemic and local oxidative stress and inflammation, alleviating inflammatory cell infiltration in plaques, and modulating lipid synthesis and transferase to alter cholesterol transport. In conclusion, the combination of metal-phenolic capsules with ATV provides a new strategy for reshaping the oxidative microenvironment of atherosclerosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Anti-inflammation | |
650 | 4 | |a Anti-oxidant | |
650 | 4 | |a Atherosclerosis | |
650 | 4 | |a Metal-phenolic framework | |
650 | 4 | |a ROS scavenging | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Reactive Oxygen Species |2 NLM | |
650 | 7 | |a Capsules |2 NLM | |
650 | 7 | |a Atorvastatin |2 NLM | |
650 | 7 | |a A0JWA85V8F |2 NLM | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
700 | 1 | |a Liu, Kaijing |e verfasserin |4 aut | |
700 | 1 | |a Liang, Xiaoyu |e verfasserin |4 aut | |
700 | 1 | |a Li, Huiyang |e verfasserin |4 aut | |
700 | 1 | |a Fu, Xue |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Ni |e verfasserin |4 aut | |
700 | 1 | |a Li, Fangjiang |e verfasserin |4 aut | |
700 | 1 | |a Yang, Jing |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanomedicine : nanotechnology, biology, and medicine |d 2005 |g 53(2023) vom: 10. Sept., Seite 102700 |w (DE-627)NLM16062021X |x 1549-9642 |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:2023 |g day:10 |g month:09 |g pages:102700 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nano.2023.102700 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 53 |j 2023 |b 10 |c 09 |h 102700 |